Multiple sclerosis patients see hope in Ann romney’s fight about MS using biotech drugs

Ann Romney’s poise as she addresses the Republican National Convention gives hope to 2.5 million multiple sclerosis sufferers, while showing how far biotechnology companies have come toward curing the once “untreatable” disease, experts told the Herald.

“Her own experience of living with MS has helped bring understanding about an unpredictable, chronic disease that has as many different faces and stories as the people living with it,” said Arney Rosenblat, spokeswoman for the National Multiple Sclerosis Society.

MS, which affects each sufferer differently, attacks the central nervous system and can cause numbness in the limbs, loss of vision and paralysis. Yet there are now eight drugs approved by the Food and Drug Administration designed to treat relapsing MS, Rosenblat said, adding there are also “multiple” MS therapies in late-stage development or before the FDA. 

View the original article here:  Multiple sclerosis patients see hope in Ann romney’s fight about MS using biotech drugs

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend